Oak Thistle LLC Reduces Chemed Corporation Stake

Hedge fund cuts holdings in healthcare services company by over two-thirds

Apr. 11, 2026 at 9:50am

Got story updates? Submit your updates here. ›

An extreme close-up of complex financial machinery and equipment, conveying a sense of institutional power and economic security without depicting any literal currency or financial symbols.The reduction in a major hedge fund's stake in a healthcare services company signals a shift in investor sentiment around the firm's performance.Cincinnati Today

Oak Thistle LLC, a hedge fund, has reduced its stake in Chemed Corporation (NYSE: CHE) by 69.2% during the fourth quarter, according to a recent 13F filing with the Securities and Exchange Commission. The fund now owns 1,834 shares of the company's stock, down from 5,947 shares previously.

Why it matters

This reduction in ownership by Oak Thistle LLC could signal a shift in sentiment around Chemed Corporation, a diversified provider of home services and healthcare solutions. As a major shareholder, Oak Thistle's decision to sell a significant portion of its stake may influence how other investors view the company's prospects.

The details

According to the 13F filing, Oak Thistle LLC sold 4,113 shares of Chemed Corporation during the fourth quarter. The fund's remaining holdings in the company are now valued at $785,000, down from $2.5 million at the end of the previous quarter.

  • Oak Thistle LLC filed the 13F report disclosing the stake reduction on April 11, 2026.
  • The hedge fund made the trades during the fourth quarter of 2025.

The players

Oak Thistle LLC

A hedge fund that has reduced its stake in Chemed Corporation by over two-thirds.

Chemed Corporation

A diversified provider of home services and healthcare solutions in the United States, headquartered in Cincinnati, Ohio.

Got photos? Submit your photos here. ›

The takeaway

The significant reduction in Oak Thistle LLC's position in Chemed Corporation could signal a shift in investor sentiment around the company's prospects. As a major shareholder, the hedge fund's decision to sell a large portion of its stake may influence how other investors view the healthcare services provider.